Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19

The use of convalescent plasma in the treatment of COVID-19 may lead to a milder course of infection and has been associated with improved outcomes. Determining optimal treatments in high risk populations is crucial, as is the case in those with hematological malignancies. We analyzed a cohort of 23...

Descripción completa

Detalles Bibliográficos
Autores principales: Biernat, Monika Maria, Kolasińska, Anna, Kwiatkowski, Jacek, Urbaniak-Kujda, Donata, Biernat, Paweł, Janocha-Litwin, Justyna, Szymczyk-Nużka, Małgorzata, Bursy, Dawid, Kalicińska, Elżbieta, Simon, Krzysztof, Mazur, Grzegorz, Wróbel, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001057/
https://www.ncbi.nlm.nih.gov/pubmed/33800528
http://dx.doi.org/10.3390/v13030436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001057/
https://www.ncbi.nlm.nih.gov/pubmed/33800528
http://dx.doi.org/10.3390/v13030436

Ejemplares similares